Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 9/20 | 0.49 |
| ▸ | MAPK10 | P53779 | 3/20 | 0.49 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.37 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.37 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.36 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13727997 | 0.93 | MAPK14 (0.53) | MAPK14MAPK10PDK2ALDH1A1L3MBTL1 | |
| SCHEMBL13727434 | 0.93 | MAPK14 (0.49) | MAPK14MAPK10PDK2L3MBTL1TDP1 | |
| SCHEMBL13728223 | 0.93 | MAPK14 (0.49) | MAPK14MAPK10PDK2L3MBTL1TDP1 | |
| SCHEMBL13726059 | 0.92 | MAPK14 (0.49) | MAPK14MAPK10PDK2ALDH1A1L3MBTL1 | |
| SCHEMBL13727149 | 0.92 | MAPK14 (0.49) | MAPK14MAPK10PDK2ALDH1A1L3MBTL1 | |
| SCHEMBL13727268 | 0.92 | PDK2 (0.47) | MAPK14MAPK10PDK2ALDH1A1L3MBTL1 | |
| SCHEMBL13726587 | 0.91 | MAPK14 (0.50) | MAPK14MAPK10PDK2ALDH1A1L3MBTL1 | |
| SCHEMBL21667422 | 0.91 | TDP1 (0.49) | PDK2ALDH1A1L3MBTL1LMNATHRB | |
| SCHEMBL4340087 | 0.90 | TDP1 (0.44) | PDK2ALDH1A1L3MBTL1LMNATHRB | |
| SCHEMBL15041040 | 0.90 | TDP1 (0.42) | ALDH1A1L3MBTL1LMNATHRBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8586740-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device using quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-11-19 | — | — | US | disclosed |
| US-20130049577-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2013-02-28 | — | — | US | disclosed |
| US-20130049577-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2013-02-28 | — | — | US | disclosed |
| US-8314101-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device using quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-11-20 | — | — | US | disclosed |
| US-20090203704-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-08-13 | — | — | US | disclosed |
| US-20090203704-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-08-13 | — | — | US | disclosed |
| EP-2065378-A1 | Quinoxaline derivate, and light-emitting element, light-emitting device, and electronic device using quinoxaline derivative | Semiconductor Energy Laboratory Co, Ltd. (JP) | 2009-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203704-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | PDXK, NQO1, PPOX | MAPK14 1573/4885MAPK10 1815/4885PDK2 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.